Grantclosed🌐 United StatesRFA-DA-20-015
Development of Clinical Outcome Assessments for Clinical Trials in Substance Use Disorders as FDA-qualified Drug Development Tools (U01 Clinical Trial Optional)
National Institutes of Health
Details?
- Posted
- Jun 25, 2019
- Response deadline
- Oct 23, 2019, 12:00 AM UTC
- Type
- Grant
- Category
- 93.279
- Status
- closed
- Buyer
- National Institutes of Health
- Department
- HHS-NIH11
- Jurisdiction
- United States
- Reference #
- RFA-DA-20-015
- Doc Type
- synopsis
- Opp Status
- archived
Finding similar opportunities…
This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.
Raw record
{
"id": "317503",
"title": "Development of Clinical Outcome Assessments for Clinical Trials in Substance Use Disorders as FDA-qualified Drug Development Tools (U01 Clinical Trial Optional)",
"agency": "National Institutes of Health",
"number": "RFA-DA-20-015",
"docType": "synopsis",
"cfdaList": [
"93.279"
],
"openDate": "06/25/2019",
"closeDate": "10/23/2019",
"oppStatus": "archived",
"agencyCode": "HHS-NIH11"
}